Literature DB >> 15350376

Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions.

Jihong Liu1, Barbara Rose, Xin Huang, Gewang Liao, Jonathan Carter, Xiaojuan Wu, Carol Thompson.   

Abstract

OBJECTIVE: To identify particular characteristics that might help explain the markedly higher rate of invasive cervical cancer in southern China as compared with Australia.
METHODS: One hundred eighty-five women with cervical cancer were recruited between 1999 and 2001: 106 from Guangzhou and Changsha (southern China), and 79 from Sydney (southeast Australia). Demographic and risk factor information was obtained by questionnaire; clinicopathologic data were extracted from hospital records. The human papillomavirus (HPV) status of cancer biopsies was ascertained by consensus PCR assays, direct sequencing and/or Amplicor trade mark hybridisation.
RESULTS: The mean age of the Chinese was significantly lower than the Australians (44 versus 53 years), although mean age at first sexual intercourse was similar. Australian women were more likely to smoke, to report multiple sexual partners and to have a history of sexually transmitted diseases (but not of genital warts). However, they were better educated, were more frequent users of barrier contraception and were far more likely to report regular Pap smears before diagnosis. The HPV positivity rate of Chinese cancers (83%) was less than Australian tumours (90%); but HPV 16 and 18 were the most common genotypes in both populations (59% and 77%), and predominated in cancers from younger women. HPV types 58 or 59 were amplified from 12 (14%) of the Chinese but from only one Australian cancer.
CONCLUSIONS: Cervical cancer is not only more common in China but also develops at a younger age than in Australia. While significant differences in some risk factors were observed, the much lower participation in cervical screening in southern China is likely to be of greatest consequence.

Entities:  

Mesh:

Year:  2004        PMID: 15350376     DOI: 10.1016/j.ygyno.2004.06.005

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.

Authors:  Matthew P Stevens; Elice Rudland; Suzanne M Garland; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing.

Authors:  Andrew Goldstein; Yang Lei; Lena Goldstein; Amelia Goldstein; Qiao Xu Bai; Juan Felix; Roberta Lipson; Maria Demarco; Mark Schiffman; Didem Egemen; Kanan T Desai; Sarah Bedell; Janet Gersten; Gail Goldstein; Karen O'Keefe; Casey O'Keefe; Tierney O'Keefe; Cathy Sebag; Lior Lobel; Anna Zhao; Yan Ling Lu
Journal:  Infect Agent Cancer       Date:  2020-10-22       Impact factor: 2.965

3.  Evaluation of high-risk human papillomaviruses type distribution in cervical cancer in Sichuan province of China.

Authors:  En-qi Wu; Guo-nan Zhang; Xiang-hui Yu; Yuan Ren; Ying Fan; Yong-ge Wu; Wei Kong; Xiao Zha
Journal:  BMC Cancer       Date:  2008-07-22       Impact factor: 4.430

4.  Epidemiologic characterization of human papillomavirus (HPV) infection in various regions of Yunnan Province of China.

Authors:  Zulqarnain Baloch; Yuanyue Li; Tao Yuan; Yue Feng; Yanqing Liu; Wenlin Tai; Li Liu; Binghui Wang; A-Mei Zhang; Xiaomei Wu; Xueshan Xia
Journal:  BMC Infect Dis       Date:  2016-05-26       Impact factor: 3.090

5.  Multiple HPV genotype infection impact on invasive cervical cancer presentation and survival.

Authors:  Maria Luiza Nogueira Dias Genta; Toni Ricardo Martins; Rossana V Mendoza Lopez; José Carlos Sadalla; João Paulo Mancusi de Carvalho; Edmund Chada Baracat; José Eduardo Levi; Jesus Paula Carvalho
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

6.  Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study.

Authors:  Mohammadreza Haghshenas; Tahereh Golini-Moghaddam; Alireza Rafiei; Omid Emadeian; Ahmad Shykhpour; G Hossein Ashrafi
Journal:  Infect Agent Cancer       Date:  2013-06-06       Impact factor: 2.965

7.  Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China.

Authors:  Yaofei Yue; Hongying Yang; Kun Wu; Lijuan Yang; Junying Chen; Xinwei Huang; Yue Pan; Youqing Ruan; Yujiao Zhao; Xinan Shi; Qiangming Sun; Qihan Li
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

8.  Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide.

Authors:  Paul K S Chan; Wendy C S Ho; Martin C W Chan; Martin C S Wong; Apple C M Yeung; Josette S Y Chor; Mamie Hui
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

9.  Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.

Authors:  Hui-Hui Xu; Kai Wang; Xing-Jun Feng; Shan-Shan Dong; Aifen Lin; Ling-Zhi Zheng; Wei-Hua Yan
Journal:  Oncotarget       Date:  2018-01-11

10.  Assessing the feasibility of a rapid, high-volume cervical cancer screening programme using HPV self-sampling and digital colposcopy in rural regions of Yunnan, China.

Authors:  Andrew Goldstein; Lena Sophia Goldstein; Roberta Lipson; Sarah Bedell; Jue Wang; Sarah A Stamper; Gal Brenner; Gail R Goldstein; Karen Davis O'Keefe; S Casey O'Keefe; McKenna O'Keefe; Tierney O'Keefe; Amelia R Goldstein; Anna Zhao
Journal:  BMJ Open       Date:  2020-03-30       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.